Navigation Links
IBA Particle Therapy's $20,000 Grant Helps Non-Profit Ease Costs for Children Traveling to Receive Proton Therapy
Date:12/23/2010

CHICAGO, Dec. 23, 2010 /PRNewswire-USNewswire/ -- IBA Particle Therapy, the worldwide leader in proton therapy, is supporting children who have cancer through a $20,000 grant to Compass to Care Childhood Cancer Foundation, a 501c(3) charitable organization. According to Michelle Ernsdorff, the founder and CEO of Compass to Care, this financial support will help provide travel and accommodation expenses families incur when traveling to proton treatment centers for their child stricken with cancer.

"Proton therapy is the most precise form of external beam radiation treatment available today," said Dr. Torunn Yock, Chief of Pediatric Radiation Oncology at Massachusetts General Hospital. "It destroys any primary residual tumor, while minimizing the harmful effects on surrounding healthy tissue and organs. It is a highly preferred radiation treatment modality option for many pediatric cases because children are more susceptible to injury from radiation therapy as their tissues and organs are still growing and developing. Proton radiotherapy cuts down the dose to normal tissues by a factor of 2-3x that which is delivered by standard non-proton radiotherapy. As a result, we are seeing fewer side effects from treatment in our pediatric patients."

Proton therapy treatment can take up to eight weeks, depending upon the location of the tumor. With only 9 operating centers in the United States, most children referred for proton therapy must travel to receive it.    Travel costs incurred to seek proton therapy treatment may include flights, lodging, meals, gasoline, car rental and/or taxi fees. In addition, most parents end up taking a leave from work, often unpaid, to stay with their child at the medical center during the treatment.

"The costs and loss of income can be financially devastating when traveling for a child's cancer care, but families will do whatever they must to help save their child's life," said Ernsdorff. "Our organization relies on donations such as the one provided by IBA to help ease some of the financial burdens families experience in these challenging situations."

"We are dedicated to protecting, enhancing and saving lives, and by standing behind the mission of Compass to Care, we are ensuring that children receive the best possible treatment with proton therapy, and are making a positive impact on the lives of these affected families," said Bill Hansen, IBA's Director of Marketing.

"We are extremely grateful for IBA's contribution to our foundation because we know what a difference this assistance makes in the lives of families as they pursue the long term health of their children," Ernsdorff continued.

For more information on how to support Compass to Care, visit www.compasstocare.org.

ABOUT IBA

Founded in 1986 in Louvain-la-Neuve, Belgium, IBA is primarily active in the medical industry. It develops and markets state-of-the-art equipment and radiopharmaceuticals for cancer diagnosis and treatment. In addition, it uses the scientific expertise thus gained to provide electron accelerators for industrial sterilization and ionization. Listed on the pan- European stock exchange Euronext, IBA is included in the BEL Mid Index (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). Website: http://www.iba-worldwide.com

ABOUT COMPASS TO CARE, THE MIKE & SANDY ERNSDORFF CHILDHOOD CANCER FOUNDATION

Compass to Care, The Mike & Sandy Ernsdorff Childhood Cancer Foundation is a 501(c)(3) charitable organization dedicated to scheduling and paying for the travel arrangements families require to seek the best cancer care for their children. Website: http://www.compasstocare.org

CONTACT: Michelle M. Ernsdorff, +1-312-515-9490, info@CompassToCare.org


'/>"/>
SOURCE Compass to Care Childhood Cancer Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
2. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
3. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
4. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
5. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
6. Particle Sciences Expands Its Combination Product Capabilities
7. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
8. Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities
9. MicroConstants Now Offers Nanoparticle Formulation Services
10. ChemImages Raman Chemical Imaging Used for Ingredient-Specific Particle Sizing for Inhalation Product Development
11. Varian Medical Systems Introduces ProBeam(TM) Proton Therapy Platform at Particle Therapy Co-operative Group (PT COG) 2010 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... 16, 2017   The Harrington Discovery Institute ... Ohio , has announced the 2017 recipients ... discoveries of physician-scientists whose research shows promise to ... Harrington Discovery Institute – part of The Harrington ... need in academic medicine: to advance early breakthroughs ...
(Date:1/16/2017)... According to the new market research report "Display Controller Market by ... LCD Controller), Application (Industrial Control, Medical Equipment, Automotive, Mobile Communication), and Geography ... to grow from USD 17.26 Billion in 2015 to reach USD 32.24 ... Continue Reading ... ...
(Date:1/16/2017)... 2017 The report "Cellulose ... (Methyl, Ethyl, Hydroxyethyl, Hydroxypropyl, Carboxymethyl Cellulose), Application ... Coatings & Paints), Region - Global Forecast ... was valued at USD 4.51 Billion in ... 6.41 Billion by 2021, at a CAGR ...
Breaking Medicine Technology:
(Date:1/14/2017)... ... , ... "TransFreeze Volume 3 is a self animating masking transition which allows users to reveal ... said Christina Austin - CEO of Pixel Film Studios. , TransFreeze Volume 3 provides ... clip to the next. , To use “Cut-Out First” presets, choose a video ...
(Date:1/13/2017)... ... ... The 18th European Congress: Perspectives in Lung Cancer will be held in ... is expertly designed to meet the educational needs of European oncology clinicians and researchers ... Dr. Giorgio V. Scagliotti, Professor of Oncology at the University of Torino, and organized ...
(Date:1/13/2017)... ... 13, 2017 , ... KOAMTAC ®, Inc., a leading manufacturer of Bluetooth ... companion scanner and data collector at the National Retail Federation’s Big Show (NRF17) held ... answer to the market’s need for more compact and rugged devices for collecting barcode ...
(Date:1/13/2017)... , ... January 13, 2017 , ... An inventor from Pahrump, Nev., used an unsavory ... urologist had me wear a Foley catheter and urine bag for a half year due ... so I decided that there should be a better way to do this." , He ...
(Date:1/13/2017)... ... January 13, 2017 , ... People who have sensitive ... of pain whenever they brush their teeth. Sadly, most dental hygiene products in the ... gums and teeth. For these people, continuing their daily oral care routine to keep ...
Breaking Medicine News(10 mins):